← k3vl4r
Log inGet started →

MIRM (Mirum Pharmaceuticals) Price Forecast

AI-generated price forecast for Mirum Pharmaceuticals (MIRM) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads MIRM as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 93.50. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

93.50

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

MIRM forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-4.96%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called MIRM's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest MIRM news

From the market-news feed the forecasts are read against.

  • Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Yahoo · Nov 12
  • Citigroup Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $194 · Benzinga · Nov 11
  • Mirum Pharmaceuticals Announces Primary Endpoint Met in AZURE-4 Phase 3 Study and Highlights Long-Term Brelovitug Data Presented at AASLD · Yahoo · Nov 10
  • No Cost Exome Testing Could Be A Game Changer For GeneDx (WGS) · Yahoo · Nov 7
  • GeneDx and Mirum to provide genetic tests for cholestasis, cataracts or PBD-ZSD · Yahoo · Nov 6

🔒

See the full MIRM forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

MIRM forecast — frequently asked

Will MIRM go up?

K3vl4r's calibrated AI forecast currently reads MIRM as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the MIRM price prediction for 2026?

K3vl4r's model projects MIRM toward $87.90 over the next ~4 weeks, a -5.0% move from $92.49. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

BJDXAKBASYIMMXPRVADFTXONCYGMABPTCTCMPSCUEASTHOABIATRC

Will MIRM reach…?

Will MIRM reach $200.00?Will MIRM reach $250.00?Will MIRM reach $500.00?

Or see the full MIRM price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare MIRM

MIRM vs BJDXMIRM vs AKBAMIRM vs SYMIRM vs IMMXMIRM vs PRVAMIRM vs DFTX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.